Catheter Precision forms new joint venture with Chelak iECG called Kardionav

Catheter Precision (VTAK) announced that it has formed a joint venture, named Kardionav, to pursue the latest in technology surrounding the area of ablation for ventricular tachycardia. The venture is a joint development company between VTAK and Chelak iECG, whereby both companies will contribute intellectual property and know-how. VTAK will own approximately 56% of the enterprise, Chelak iECG will own 33%, and management will have 10% ownership.